TG Therapeutics, Inc.
Developing novel B-cell treatments
- B2B
About TG Therapeutics, Inc.
Biopharmaceutical company specializing in developing and commercializing novel treatments for B-cell diseases, with a focus on relapsing forms of multiple sclerosis
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- morrisville, north carolina, United States
- Founded
- 2011
- Revenue
- $616MFY2025, publicly reported
- Website
- tgtherapeutics.com
TG Therapeutics, Inc. at a glance
TG Therapeutics, Inc. is a B2B company in the Biotechnology Research industry, headquartered in morrisville, north carolina, United States.
TG Therapeutics, Inc. was founded in 2011.
TG Therapeutics, Inc. has 251–1,000 employees.
TG Therapeutics, Inc.'s revenue is $616M (FY2025, publicly reported).
Selling to companies like TG Therapeutics, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies